Chargement en cours...
DPP‐4 inhibitors promote proliferation and migration of rat brain microvascular endothelial cells under hypoxic/high‐glucose conditions, potentially through the SIRT1/HIF‐1/VEGF pathway
BACKGROUND: Vascular disease in diabetes, for example, stroke, presents a significant public health burden. Recently, the dipeptidyl peptidase 4 (DPP‐4) inhibitor linagliptin has been found to counteract stroke among diabetic patients, showing great promise in drug repurposing and indication expansi...
Enregistré dans:
| Publié dans: | CNS Neurosci Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488877/ https://ncbi.nlm.nih.gov/pubmed/30136405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13042 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|